These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30032025)

  • 1. Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes.
    Palanca A; Castelblanco E; Perpiñán H; Betriu À; Soldevila B; Valdivielso JM; Bermúdez M; Duran X; Fernández E; Puig-Domingo M; Groop PH; Alonso N; Mauricio D
    Atherosclerosis; 2018 Sep; 276():50-57. PubMed ID: 30032025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.
    Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):287-96. PubMed ID: 26668022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease.
    Palanca A; Castelblanco E; Betriu À; Perpiñán H; Soldevila B; Valdivielso JM; Bermúdez-Lopez M; Puig-Jové C; Puig-Domingo M; Groop PH; Fernández E; Alonso N; Mauricio D
    Cardiovasc Diabetol; 2019 Jul; 18(1):93. PubMed ID: 31324183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study.
    Betriu A; Martinez-Alonso M; Arcidiacono MV; Cannata-Andia J; Pascual J; Valdivielso JM; Fernández E;
    Nephrol Dial Transplant; 2014 Jul; 29(7):1415-22. PubMed ID: 24586070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical peripheral arterial disease in rheumatoid arthritis.
    Stamatelopoulos KS; Kitas GD; Papamichael CM; Kyrkou K; Zampeli E; Fragiadaki K; Panoulas VF; Mavrikakis M; Sfikakis PP
    Atherosclerosis; 2010 Sep; 212(1):305-9. PubMed ID: 20553683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: The role of cholesterol burden and gender.
    Mattina A; Giammanco A; Giral P; Rosenbaum D; Carrié A; Cluzel P; Redheuil A; Bittar R; Béliard S; Noto D; Quartarone A; Averna M; Bruckert É; Gallo A
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1068-1076. PubMed ID: 31378630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance and prevalence of subclinical atherosclerosis in different vascular territories.
    Moreyra E; Moreyra C; Tibaldi MA; Crespo F; Arias V; Lepori AJ; Moreyra EA
    Vascular; 2020 Jun; 28(3):285-294. PubMed ID: 31964294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of subclinical carotid atherosclerosis and its relationship with echocardiographic parameters in non-diabetic chronic kidney disease patients.
    Kim JK; Song YR; Kim MG; Kim HJ; Kim SG
    BMC Cardiovasc Disord; 2013 Nov; 13():96. PubMed ID: 24192205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study.
    López-Melgar B; Fernández-Friera L; Oliva B; García-Ruiz JM; Peñalvo JL; Gómez-Talavera S; Sánchez-González J; Mendiguren JM; Ibáñez B; Fernández-Ortiz A; Sanz J; Fuster V
    J Am Coll Cardiol; 2017 Jul; 70(3):301-313. PubMed ID: 28705310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes.
    Carbonell M; Castelblanco E; Valldeperas X; Betriu À; Traveset A; Granado-Casas M; Hernández M; Vázquez F; Martín M; Rubinat E; Lecube A; Franch-Nadal J; Fernández E; Puig-Domingo M; Avogaro A; Alonso N; Mauricio D
    Cardiovasc Diabetol; 2018 May; 17(1):66. PubMed ID: 29728117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference.
    Martín M; Valls J; Betriu A; Fernández E; Valdivielso JM
    Atherosclerosis; 2015 Jul; 241(1):264-70. PubMed ID: 25748053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Burden of Carotid and Femoral Atherosclerosis in Subjects Without Known Cardiovascular Disease in a Large Community Hospital in South-America.
    Botto F; Obregon S; Forcada P; Di Leva A; Fischer Sohn G; Bang JH; Koretzky M; Baratta S; Kotliar C
    High Blood Press Cardiovasc Prev; 2024 Mar; 31(2):177-187. PubMed ID: 38436891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological comorbidities associated with subclinical atherosclerosis in Greek patients with primary Sjögren's syndrome: a potential contribution of sleep impairment.
    Karageorgas T; Ioakeimidis D; Mavragani CP
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):68-72. PubMed ID: 29148412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of longitudinal distribution of subclinical atherosclerosis in femoral arteries by three-dimensional cardiovascular magnetic resonance vessel wall imaging.
    Han Y; Guan M; Zhu Z; Li D; Chen H; Yuan C; Li C; Wang W; Zhao X
    J Cardiovasc Magn Reson; 2018 Sep; 20(1):60. PubMed ID: 30173671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study.
    Fernández-Friera L; Peñalvo JL; Fernández-Ortiz A; Ibañez B; López-Melgar B; Laclaustra M; Oliva B; Mocoroa A; Mendiguren J; Martínez de Vega V; García L; Molina J; Sánchez-González J; Guzmán G; Alonso-Farto JC; Guallar E; Civeira F; Sillesen H; Pocock S; Ordovás JM; Sanz G; Jiménez-Borreguero LJ; Fuster V
    Circulation; 2015 Jun; 131(24):2104-13. PubMed ID: 25882487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Diabetes and Time on the Atherosclerotic Plaque and Cardiovascular Outcome in Patients Undergoing Iliofemoral Endarterectomy.
    van Koeverden ID; Scholtes VPW; den Ruijter HM; Hazenberg SCE; de Kleijn DPV; de Borst GJ
    Eur J Vasc Endovasc Surg; 2019 Jun; 57(6):832-841. PubMed ID: 30910497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project.
    Sánchez E; Betriu À; López-Cano C; Hernández M; Fernández E; Purroy F; Bermúdez-López M; Farràs-Sallés C; Barril S; Pamplona R; Rius F; Hernández C; Simó R; Lecube A;
    Cardiovasc Diabetol; 2019 Nov; 18(1):154. PubMed ID: 31729979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.
    Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E;
    Nephrol Dial Transplant; 2017 Mar; 32(3):513-520. PubMed ID: 27190385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound.
    Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E;
    PLoS One; 2017; 12(10):e0186665. PubMed ID: 29045466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.